FDA approves NVS’ Kymriah (CTL019 CAR-T) for pediatric ALL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm I don't consider CAR-T a form of gene therapy, but the FDA does, evidently.